✦ LIBER ✦

Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101

✍ Scribed by P.C. Adamson; S.M. Blaney; B.C. Widemann; B. Kitchen; R.F. Murphy; A.L. Hannah; G.F. Cropp; M. Patel; A.F. Gillespie; P.G. Whitcomb; F.M. Balis

Book ID: 105991928
Publisher: Springer
Year: 2004
Tongue: English
Weight: 218 KB
Volume: 53
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-004-0769-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet-Derived Growth Factor Receptor

Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer

✍ Mathew, P. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 303 KB

Phase I pharmacokinetic study of the vas

Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma

✍ David A. Reardon; Merrill J. Egorin; Annick Desjardins; James J. Vredenburgh; Ja 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 1 views

Phase I and pharmacokinetic study of BIB

Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

✍ Ch. Dittrich; G. Greim; M. Borner; K. Weigang-Köhler; H. Huisman; A. Amelsberg; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Phase I and pharmacokinetic study of BIB

Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

✍ Ch. Dittrich; G. Greim; M. Borner; K. Weigang-Köhler; H. Huisman; A. Amelsberg; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Phase I dose-finding and pharmacokinetic

Phase I dose-finding and pharmacokinetic study of the oral epidermal growth factor receptor tyrosine kinase inhibitor Ro50-8231 (erlotinib) in Japanese patients with solid tumors

✍ Noboru Yamamoto; Atsushi Horiike; Yasuhito Fujisaka; Haruyasu Murakami; Tatsu Sh 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 367 KB

Phase I Clinical and Pharmacokinetic Stu

Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors

✍ Strumberg, D. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 207 KB